Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;36(2):223-236.
doi: 10.1007/s00467-020-04487-6. Epub 2020 Feb 3.

Adult complications of nephropathic cystinosis: a systematic review

Affiliations

Adult complications of nephropathic cystinosis: a systematic review

Rachel Nora Kasimer et al. Pediatr Nephrol. 2021 Feb.

Abstract

While nephropathic cystinosis is classically thought of as a childhood disease, with improved treatments, patients are more commonly living into adulthood. We performed a systematic review of the literature available on what complications this population faces as it ages. Nearly every organ system is affected in cystinosis, either from the disease itself or from sequelae of kidney transplantation. While cysteamine is known to delay the onset of end-stage kidney disease, its effects on other complications of cystinosis are less well determined. More common adult-onset complications include myopathy, diabetes, and hypothyroidism. Some less common complications, such as neurologic dysfunction, can still have a profound impact on those with cystinosis. Areas for further research in this area include additional study of the impact of cysteamine on the nonrenal manifestations of cystinosis, as well as possible avenues for new and novel treatments.

Keywords: Adult complications; Cardiovascular disease; Chronic kidney disease; Cystinosis; Endocrinopathies; Fanconi syndrome.

PubMed Disclaimer

References

    1. Langman CB, Barshop BA, Deschênes G, Emma F, Goodyer P, Lipkin G, Midgley JP, Ottolenghi C, Servias A, Soliman NA, Thoene JG, Levtchenko EN (2016) Controversies and research agenda in nephropathic cystinosis: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int 89:1192–1203 - PubMed
    1. Langman CB (2019) Oh cystinosin: let me count the ways! Kidney Int 96:275–277 - PubMed
    1. Emma F, Nesterova G, Langman C, Labbé A, Chergui S, Goodyer P, Janssen MC, Greco M, Topaloglu R, Elenberg E, Dohil, Trauner D, Antignac C, Cochat P, Kaskel F, Servais A, Wühl E, Niaudet P, Van’t Hoff W, Gahl W, Levtchenko E (2014) Nephropathic cystinosis: an international consensus document. Nephrol Dial Transplant 29(Suppl 4):iv87–iv94 - PubMed - PMC
    1. OCEBM Levels of Evidence Working Group. “The Oxford Levels of Evidence 1”. Oxford Centre for Evidence-Based Medicine
    1. Sharma R (2015) Cystinosis in an adult metabolic clinic – a truly multi-systemic disease requiring multi-professional and multidisciplinary management. J Inherit Metab Dis 38:S289

Publication types

LinkOut - more resources